Minimal Access and Bariatric Surgery Centre, Sir Ganga Ram Hospital, Room No. 200, Old Rajinder Nagar, New Delhi, 110060, India.
Obes Surg. 2010 Oct;20(10):1340-7. doi: 10.1007/s11695-009-9973-9. Epub 2009 Sep 29.
Obesity has been observed to be on the rise in the Indian subcontinent. We report our early experience with the laparoscopic sleeve gastrectomy (LSG) for treating morbid obesity in the Indian population along with description of the surgical technique.
The data of 75 patients who underwent LSG for the treatment of morbid obesity at the Minimal Access, Metabolic and Bariatric Surgery Centre, Sir Ganga Ram Hospital, Delhi, from November 2006 to February 2009, were retrospectively reviewed from prospective database. The gastric sleeve is created laparoscopically using sequential firings of a linear stapling device applied alongside a 36-Fr calibrating bougie. The data collected included age, gender, initial body mass index (BMI) and excess weight, the co-morbidity status, and preoperative investigations. Perioperative parameters and follow-up details [weight, BMI, excess weight loss (%EWL), resolution of co-morbidities, and postoperative investigations] were noted.
All procedures were completed laparoscopically. There was no major procedure-related morbidity. Hemorrhage requiring blood transfusion was observed in four patients. One patient died at 2 weeks postoperatively due to pulmonary embolism. There was a steady rise in %EWL from 31.2% at 3 months to 52.3% at 6 months, 59.13% at 1 year, and 65% at 2 years. Type II diabetes was resolved in 81.2%, hypertension in 93.75%, and dyslipidemia in 85% at 1 year.
Although long-term results are necessary to determine the benefits of the procedure, early results indicate that LSG may be a safe and feasible option for treating the morbidly obese patients.
在印度次大陆,肥胖问题已呈上升趋势。我们报告了在印度人群中使用腹腔镜袖状胃切除术(LSG)治疗病态肥胖的早期经验,并描述了手术技术。
回顾性分析 2006 年 11 月至 2009 年 2 月在德里 Sir Ganga Ram 医院微创、代谢和减重外科中心接受 LSG 治疗病态肥胖的 75 例患者的资料,这些数据均来自前瞻性数据库。使用线性吻合器沿 36Fr 校准探条连续点火,在腹腔镜下创建胃袖套。收集的数据包括年龄、性别、初始体重指数(BMI)和超重、合并症状态以及术前检查。记录围手术期参数和随访细节[体重、BMI、超重减轻百分比(%EWL)、合并症的缓解情况以及术后检查]。
所有手术均在腹腔镜下完成。无与手术相关的严重并发症。4 例患者发生需要输血的出血。1 例患者术后 2 周死于肺栓塞。%EWL 从术后 3 个月的 31.2%稳步上升至 6 个月的 52.3%、1 年的 59.13%和 2 年的 65%。1 年内 81.2%的患者 2 型糖尿病得到缓解,93.75%的患者高血压得到缓解,85%的患者血脂异常得到缓解。
尽管需要长期结果来确定该手术的益处,但早期结果表明 LSG 可能是治疗病态肥胖患者的一种安全可行的选择。